Annovis Bio, Inc. (ANVS)
NYSE·Healthcare·Biotechnology
$1.89
+5.59%
Mkt Cap $50.56M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (3 analysts)
$25.67
Range $21.00 – $30.00
Implied Upside
+1261.8%
Consensus $25.67 vs current $1.89
NYSE·Healthcare·Biotechnology
$1.89
+5.59%
Mkt Cap $50.56M
Buy
1
Hold
0
Sell
0
Price Target (3 analysts)
$25.67
Range $21.00 – $30.00
+1261.8%
Consensus $25.67 vs current $1.89